Shanghai Allist Pharmaceuticals Co Ltd Class A 688578
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 59.58
- Day Range
- CNY 59.08–60.18
- 52-Week Range
- CNY 22.16–68.87
- Bid/Ask
- CNY 59.59 / CNY 59.60
- Market Cap
- CNY 26.82 Bil
- Volume/Avg
- 4.4 Mil / 5.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 29.51
- Price/Sales
- 10.89
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Shanghai Allist Pharmaceuticals Co Ltd is an innovative drug company in the field of cancer treatment.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Large Growth
- Total Number of Employees
- 870
- Website
- http://www.allist.com.cn
Comparables
Valuation
|
Metric
|
688578
|
688197
|
688278
|
|---|---|---|---|
Price/Earnings (Normalized) | 29.51 | — | 37.58 |
Price/Book Value | 6.21 | 7.63 | 11.70 |
Price/Sales | 10.89 | 1,410.94 | 10.52 |
Price/Cash Flow | 25.52 | — | 41.15 |
Price/Earnings
688578
688197
688278
Financial Strength
|
Metric
|
688578
|
688197
|
688278
|
|---|---|---|---|
Quick Ratio | 7.91 | 5.50 | 3.12 |
Current Ratio | 8.35 | 8.50 | 3.84 |
Interest Coverage | 7,084.53 | −2,090.39 | 1,367.33 |
Quick Ratio
688578
688197
688278
Profitability
|
Metric
|
688578
|
688197
|
688278
|
|---|---|---|---|
Return on Assets (Normalized) | 21.96% | −18.00% | 29.32% |
Return on Equity (Normalized) | 23.84% | −19.55% | 36.30% |
Return on Invested Capital (Normalized) | 22.94% | −21.58% | 35.79% |
Return on Assets
688578
688197
688278
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Kgsghbbk | Kxrs | $586.1 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Gfkyfdjhz | Mjqpgx | $113.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Bjkbqbbvj | Swvby | $108.2 Bil | |
MRNA
| Moderna Inc | Tljtgfnl | Swwr | $50.9 Bil | |
ARGX
| argenx SE ADR | Cbgpnlq | Htlfc | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Nckqhqzxm | Npqbz | $21.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Qlpkvws | Gwdxr | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Sgbfpftq | Fmbqvj | $14.6 Bil | |
INCY
| Incyte Corp | Bldhjkm | Zkldcch | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Qrshczmpq | Qjfmwyg | $12.3 Bil |